
Sign up to save your podcasts
Or


This week on BioTech Nation, Dr. Thomas Chen, Director of Neuro-Oncology at USC and Founder of NeOnc Technologies, shares treating glioblastoma by delivering a drug directly to the brain through nasal inhalation changes the drug delivery game, bypassing the blood-brain barrier. This technique is achieving results in clinical trials.
By Moira Gunn4.1
2929 ratings
This week on BioTech Nation, Dr. Thomas Chen, Director of Neuro-Oncology at USC and Founder of NeOnc Technologies, shares treating glioblastoma by delivering a drug directly to the brain through nasal inhalation changes the drug delivery game, bypassing the blood-brain barrier. This technique is achieving results in clinical trials.

21,968 Listeners

43,850 Listeners

32,012 Listeners

30,699 Listeners

43,592 Listeners

707 Listeners

6,409 Listeners

30,219 Listeners

125 Listeners

320 Listeners

9,904 Listeners

34 Listeners

18 Listeners

48 Listeners

138 Listeners